Kiniksa Pharmaceuticals International Plc (KNSA)
80.79
+1.09
(+1.37%)
USD |
NASDAQ |
Oct 22, 16:00
80.72
-0.07
(-0.09%)
After-Hours: 20:00
Kiniksa Pharmaceuticals International Market Cap : 6.300B for Oct. 22, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 22, 2026 | 6.300B |
| October 21, 2026 | 6.215B |
| October 20, 2026 | 6.486B |
| October 19, 2026 | 6.198B |
| October 16, 2026 | 6.128B |
| October 15, 2026 | 6.234B |
| October 14, 2026 | 6.148B |
| October 13, 2026 | 6.124B |
| October 12, 2026 | 6.179B |
| October 09, 2026 | 6.221B |
| October 08, 2026 | 6.141B |
| October 07, 2026 | 6.079B |
| October 06, 2026 | 6.011B |
| October 05, 2026 | 5.951B |
| October 02, 2026 | 5.910B |
| October 01, 2026 | 5.866B |
| September 30, 2026 | 5.818B |
| September 29, 2026 | 5.905B |
| September 28, 2026 | 5.934B |
| September 25, 2026 | 5.855B |
| September 24, 2026 | 5.875B |
| September 23, 2026 | 5.933B |
| September 22, 2026 | 6.082B |
| September 21, 2026 | 6.093B |
| September 18, 2026 | 6.023B |
| Date | Value |
|---|---|
| September 17, 2026 | 6.186B |
| September 16, 2026 | 6.053B |
| September 15, 2026 | 5.860B |
| September 14, 2026 | 5.972B |
| September 11, 2026 | 5.948B |
| September 10, 2026 | 5.964B |
| September 09, 2026 | 6.123B |
| September 08, 2026 | 6.011B |
| September 04, 2026 | 6.075B |
| September 03, 2026 | 6.275B |
| September 02, 2026 | 6.230B |
| September 01, 2026 | 6.182B |
| August 31, 2026 | 6.132B |
| August 28, 2026 | 6.089B |
| August 27, 2026 | 6.223B |
| August 26, 2026 | 6.135B |
| August 25, 2026 | 6.254B |
| August 24, 2026 | 6.190B |
| August 21, 2026 | 6.163B |
| August 20, 2026 | 6.119B |
| August 19, 2026 | 6.301B |
| August 18, 2026 | 6.199B |
| August 17, 2026 | 6.174B |
| August 14, 2026 | 5.985B |
| August 13, 2026 | 6.069B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Autolus Therapeutics Plc | 420.54M |
| Scancell Holdings Plc | 146.33M |
| OptiBiotix Health Plc | 11.36M |
| Adaptimmune Therapeutics Plc | 6.626M |
| Oxford Biomedica Plc | 877.30M |
Market Cap Related Metrics
| PE Ratio | 82.15 |
| PS Ratio | 7.864 |
| PEG Ratio | 0.0357 |
| Price to Book Value | 9.631 |
| Price to Free Cash Flow | 36.17 |
| Price | 80.79 |
| Earnings Yield | 1.22% |
| PEGY Ratio | 0.0357 |
| Operating PE Ratio | 65.96 |
| Normalized PE Ratio | 82.15 |